# Franklin W. Maddux

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/franklin-w-maddux/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,064 |
| Field | Dialysis and Renal Disease Management |
| h-index | 31 |
| i10-index | 77 |
| Last Known Institution | Fresenius Medical Care (United States) |
| OpenAlex ID | https://openalex.org/A5069296608 |
| ORCID iD | 0000-0003-1395-2011 |
| Works | 288 |

## Researcher papers

- [Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis](https://scholariq.org/papers/dabigatran-and-rivaroxaban-use-in-atrial-fibrillation-patients-on-hemodialysis/)
- [Intradialytic hypotension: Frequency, sources of variation and correlation with clinical outcome](https://scholariq.org/papers/intradialytic-hypotension-frequency-sources-of-variation-and-correlation-with/)
- [Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF](https://scholariq.org/papers/nonvitamin-k-anticoagulant-agents-in-patients-with-advanced-chronic-kidney/)
- [A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors](https://scholariq.org/papers/a-nationally-representative-study-of-calcific-uremic-arteriolopathy-risk-factors/)
- [Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS)](https://scholariq.org/papers/dialysate-potassium-serum-potassium-mortality-and-arrhythmia-events-in/)
- [Improving Clinical Outcomes Among Hemodialysis Patients: A Proposal for a “Volume First” Approach From the Chief Medical Officers of US Dialysis Providers](https://scholariq.org/papers/improving-clinical-outcomes-among-hemodialysis-patients-a-proposal-for-a-volume/)
- [Early Outcomes among Those Initiating Chronic Dialysis in the United States](https://scholariq.org/papers/early-outcomes-among-those-initiating-chronic-dialysis-in-the-united-states/)
- [Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/challenges-in-conducting-clinical-trials-in-nephrology-conclusions-from-a-kidney/)
- [First-Year Outcomes of Incident Peritoneal Dialysis Patients in the United States](https://scholariq.org/papers/first-year-outcomes-of-incident-peritoneal-dialysis-patients-in-the-united/)
- [Adherence Barriers to Chronic Dialysis in the United States](https://scholariq.org/papers/adherence-barriers-to-chronic-dialysis-in-the-united-states/)
- [European Nephrologists’ Attitudes toward the Application of Artificial Intelligence in Clinical Practice: A Comprehensive Survey](https://scholariq.org/papers/european-nephrologists-attitudes-toward-the-application-of-artificial/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Central Venous Catheters and Hemodialysis](https://scholariq.org/topics/central-venous-catheters-and-hemodialysis/)
- [Climate Change and Health Impacts](https://scholariq.org/topics/climate-change-and-health-impacts/)

## Researcher university

- [Fresenius Medical Care (United States)](https://scholariq.org/institutions/fresenius-medical-care-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.